SKU: QCEG-7
 
GAG EndoNRE QC DBS Set (7-levels): DBS prepared with pooled whole blood spiked to yield seven concentrations of qNMR certified IdoUA-GlcNAc6S (IDUA), IdoUA2S-GlcNAc (I2S), and GlcNS-GlcUA (SGSH).
 
Each set includes one card from each concentration with 5 DBS per level.

GAG EndoNRE Triplex QC DBS, 7-Level Set

SKU: QCEG-7

Quantity

Herbst, Z.M., Urdaneta, L., Klein, T., Fuller, M. and Gelb, M.H., 2020. Evaluation of multiple methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis-I. International journal of neonatal screening, 6(3), p.69.

Herbst, Z.M., Urdaneta, L., Klein, T., Burton, B.K., Basheeruddin, K., Liao, H.C., Fuller, M. and Gelb, M.H., 2022. Evaluation of two methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis Type II. International Journal of Neonatal Screening, 8(1), p.9.

Herbst, Z.M., Kubaski, F., Pollard, L., Basheeruddin, K., Burton, B., Orsini, J., Henderson, M., Chakraborty, P. and Gelb, M.H., 2025. High precision newborn screening for mucopolysaccharidosis type I by enzymatic activity followed by endogenous, non-reducing end glycosaminoglycan analysis. Molecular genetics and metabolism, 144(2), p.108612.

Gholap, S.P., Herbst, Z., Paranji, R.K. and Gelb, M.H., 2025. Synthesis of the endogenous non-reducing end heparan sulfate disaccharide for newborn screening and diagnosis of Mucopolysaccharidosis type IIIA. Carbohydrate research, 555, p.109584.

Singh, G., Gholap, S.P., Lim, S., Herbst, Z.M. and Gelb, M.H., 2026. Synthesis of the Endogenous Non-Reducing End Heparan Sulfate Disaccharides for Newborn Screening and Diagnosis of Mucopolysaccharidosis types I and II. Carbohydrate Research, p.110100. DOI: 10.1016/j.carres.2026.110100

GAG EndoNRE Triplex QC DBS, 7-Level Set

Relevant Literature